Patents by Inventor Melvyn Lynn

Melvyn Lynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7348316
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: March 25, 2008
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Daniel P. Rossignol, Melvyn Lynn, Clifford DiLea
  • Publication number: 20060051821
    Abstract: The invention provides methods and kits for use in determining whether a patient may benefit from treatment with a toll-like receptor 4 (TLR4) antagonist, such as an antiendotoxin compound.
    Type: Application
    Filed: February 12, 2004
    Publication date: March 9, 2006
    Inventors: Daniel Rossignol, Melvyn Lynn
  • Publication number: 20050215517
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: September 29, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, William Kerns
  • Publication number: 20050153929
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: July 14, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea
  • Publication number: 20050101549
    Abstract: This invention provides methods of preventing and treating endotoxemia and related complications associated with surgical procedures, such as cardiac surgical procedures, by administration of an antiendotoxin compound.
    Type: Application
    Filed: May 12, 2004
    Publication date: May 12, 2005
    Inventor: Melvyn Lynn
  • Publication number: 20040127456
    Abstract: This invention provides methods of preventing and treating endotoxemia and related complications associated with surgical procedures, such as cardiac surgical procedures, by administration of an antiendotoxin compound.
    Type: Application
    Filed: May 7, 2003
    Publication date: July 1, 2004
    Inventor: Melvyn Lynn
  • Publication number: 20030190313
    Abstract: The invention provides methods and kits for determining whether a patient may benefit from treatment with an anti-endotoxin compound.
    Type: Application
    Filed: June 5, 2003
    Publication date: October 9, 2003
    Inventors: Daniel P. Rossignol, Melvyn Lynn
  • Publication number: 20030130212
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 13, 2002
    Publication date: July 10, 2003
    Inventors: Daniel P. Rossignol, Melvyn Lynn, William D. Kerns
  • Publication number: 20030105033
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by bolus or intermittent intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 13, 2002
    Publication date: June 5, 2003
    Inventors: Daniel P. Rossignol, Melvyn Lynn, Clifford DiLea
  • Publication number: 20020042379
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by bolus or intermittent intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 11, 2001
    Publication date: April 11, 2002
    Inventors: Daniel Rossignol, Melvyn Lynn, Clifford DiLea